Loftsson, T., Brewster, M.E., Pharmaceutical applications of cyclodextrins: 1 (1996) Drug solubilization and stabilization. J. Pharm. Sci., 85, pp. 1017-1025
Loftsson, T., Másson, M., Sigurdsson, H.H., Magnusson, P., Le Goffic, F., Cyclodextrins as co-enhancers in dermal and transdermal drug delivery (1998) Pharmazie, 53, pp. 137-139
Loftsson, T., Ólafsson, J.H., Cyclodextrins: new drug delivery systems in dermatology (1998) Int. J. Dermatol., 37, pp. 241-246
Loftsson, T., Másson, M., Cyclodextrins in topical drug formulations: theory and practice (2001) Int. J. Pharm., 225, pp. 15-30
Loftsson, T., Máasson, M., Sigurdsson, H.H., Cyclodextrins and drug permeability through semi-permeable cellophane membranes (2002) Int. J. Pharm., 232, pp. 35-43
Loftsson, T., Vogensen, S.B., Brewster, M.E., Konradsdóttir, F., Effects of cyclodextrins on drug delivery through biological membranes (2007) J. Pharm. Sci., 96, pp. 2532-2546
Loftsson, T., Duchêne, D., Cyclodextrins and their pharmaceutical applications (2007) Int. J. Pharm., 329, pp. 1-11
Másson, M., Loftsson, T., Másson, G., Stefánsson, E., Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing (1999) J. Control. Release, 59, pp. 107-118
Matsuda, H., Arima, H., Cyclodextrins in transdermal and rectal delivery (1999) Adv. Drug Deliv. Rev., 36, pp. 81-99
Challa, R., Ahuja, A., Ali, J., Khar, R.K., Cyclodextrins in drug delivery: an updated review (2005) AAPS PharmSciTech, 6, pp. 329-357
Cal, K., Centkowska, K., Use of cyclodextrins in topical formulations: practical aspects (2008) Eur. J. Pharm. Biopharm., 68, pp. 467-478
Okamoto, H., Komatsu, H., Hashida, M., Sezaki, H., Effects of b-cyclodextrin and di-O-methyl-b-cyclodextrin on the percutaneous-absorption of butylparaben, indomethacin and sulfanilic acid (1986) Int. J. Pharm., 30, pp. 35-45
Vollmer, U., Muller, B.W., Peeters, J., Mesens, J., Wilffert, B., Peters, T., A study of the percutaneous absorptionenhancing effects of cyclodextrin derivatives in rats (1994) J. Pharm. Pharmacol., 46, pp. 19-22
Hovgaard, L., Brøndsted, H., Drug delivery studies in Caco-2 monolayers: IV (1995) Absorption enhancer effects of cyclodextrins. Pharm. Res., 12, pp. 1328-1332
Legendre, J.Y., Rault, I., Petit, A., Luijten, W., Demuynck, I., Horvath, S., Ginot, Y.M., Cuine, A., Effects of b-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977 (1995) Eur. J. Pharm. Sci., 3, pp. 311-322
Vitoria, M., Bentley, L.B., Vianna, R.F., Wilson, S., Collett, J.H., Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse (1997) J. Pharm. Pharmacol., 49, pp. 397-402
Irie, T., Uekama, K., Pharmaceutical applications of cyclodextrins: 3 (1997) Toxicological issues and safety evaluation. J. Pharm. Sci., 86, pp. 147-162
Ventura, C.A., Tommasini, S., Falcone, A., Giannone, I., Paolino, D., Sdrafkakis, V., Mondello, M.R., Puglisi, G., Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin (2006) Int. J. Pharm., 314, pp. 37-45
Bochot, A., Duchêne, D., Cyclodextrines (2006) Actifs et additifs en cosmétologie, pp. 993-1018. , In: Doc, T., Ed., Lavoisier, Paris
Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G.E., Perly, B., Delattre, L., Evrard, B., Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay (2004) Eur. J. Pharm. Biopharm., 57, pp. 479-482
Babu, R.J., Pandit, J.K., Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin (2004) Int. J. Pharm., 271, pp. 155-165
Rode, T., Frauen, M., Muller, B.W., Dusing, H.J., Schonrock, U., Mundt, C., Wenck, H., Complex formation of sericoside with hydrophilic cyclodextrins: improvement of solubility and skin penetration in topical emulsion based formulations (2003) Eur. J. Pharm. Biopharm., 55, pp. 191-198
Loftsson, T., Petersen, D.S., Cyclodextrin solubilization of water-insoluble drugs: calcipotriol and EB-1089 (1997) Pharmazie, 52, pp. 783-785
Adachi, H., Irie, T., Hirayama, F., Uekama, K., Stabilization of prostaglandin-E1 in fatty alcohol propyleneglycol ointment by acidic cyclodextrin derivative, orthocarboxymethyl-ortho-ethyl-b-cyclodextrin (1992) Chem. Pharm. Bull., 40, pp. 1586-1591
Weisse, S., Perly, B., Creminon, C., Ouvrard-Baraton, F., Djedaïni-Pilard, F., Enhancement of vitamin A skin absorption by cyclodextrins (2004) STP Pharm. Sci., 14, pp. 77-86
Potts, R.O., Mcneill, S.C., Desbonnet, C.R., Wakshull, E., Transdermal drug transport and metabolism: 2 (1989) The role of competing kinetic events. Pharm. Res., 6, pp. 119-124
Chan, S.Y., Po, A.L.W., Prodrugs for dermal delivery (1989) Int. J. Pharm., 55, pp. 1-16
Liu, P.H., Higuchi, W.I., Ghanem, A.H., Kuriharabergstrom, T., Good, W.R., Quantitation of simultaneous diffusion and metabolism of b-estradiol in hairless mouse skin: enzyme distribution and intrinsic diffusion metabolism parameters (1990) Int. J. Pharm., 64, pp. 7-25
Uekama, K., Adachi, H., Irie, T., Yano, T., Saita, M., Noda, K., Improved transdermal delivery of prostaglandin-E1 through hairless mouse skin: combined use of carboxymethylethyl-b-cyclodextrin and penetration enhancers (1992) J. Pharm. Pharmacol., 44, pp. 119-121
Lopez, R.F.V., Collett, J.H., Bentley, M.V.L.B., Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone (2000) Int. J. Pharm., 200, pp. 127-132
Anadolu, R.Y., Sen, T., Tarimci, N., Birol, A., Erdem, C., Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi (2004) J. Eur. Acad. Dermatol. Venereol., 18, pp. 416-421
Amdidouche, D., Darrouzet, H., Duchêne, D., Poelman, M.C., Inclusion of retinoic acid in b-cyclodextrin (1989) Int. J. Pharm., 54, pp. 175-179
Irie, T., Uekama, K., Protection against the photosensitized skin irritancy of chlorpromazine by cyclodextrin complexation (1985) J. Pharmacobio-Dyn., 8, pp. 788-791
Hoshino, T., Ishida, K., Irie, T., Uekama, K., Ono, T., An attempt to reduce the photosensitizing potential of chlorpromazine with the simultaneous use of b-cyclodextrins and dimethyl-b-cyclodextrins in guinea-pigs (1989) Arch. Dermatol. Res., 281, pp. 60-65
Daniels, R., Knie, U., Galenics of dermal products: vehicles, properties and drug release (2007) J. Dtsch. Dermatol. Gesellsch., 5, pp. 367-383
Arima, H., Miyaji, T., Irie, T., Hirayama, F., Uekama, K., Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by b-cyclodextrin derivatives in hydrophilic ointment (1996) Chem. Pharm. Bull., 44, pp. 582-586
Bilensoy, E., Rouf, M.A., Vural, I., Şen, M., Hincal, A.A., Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: b-cyclodextrin complex (2006) AAPS PharmSciTech, 7, pp. 1-7
Blanco-Fuente, H., Esteban-Fernández, B., Blanco-Méndez, J., Otero-Espinar, F.J., Use of b-cyclodextrins to prevent modifications of the properties of carbopol hydrogels due to carbopol-drug interactions (2002) Chem. Pharm. Bull., 40, pp. 40-46
Boulmedarat, L., Grossiord, J.L., Fattal, E., Bochot, A., Influence of methyl-b-cyclodextrin and liposomes on rheological properties of Carbopol (R) 974P NF gels (2003) Int. J. Pharm., 254, pp. 59-64
Kim, E., Gao, Z., Park, J., Li, H., Han, K., rhEGF/HPb-CD complex in poloxamer gel for ophthalmic delivery (2002) Int. J. Pharm., 233, pp. 159-167
Doliwa, A., Santoyo, S., Ygartua, P., Influence of piroxicam: hydroxypropyl-b-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam (2001) Skin Pharmacol. Appl. Skin Physiol., 14, pp. 97-107
Harada, A., Preparation and structures of supramolecules between cyclodextrins and polymers (1996) Coord. Chem. Rev., 148, pp. 115-133
Uekama, K., Ikeda, Y., Hirayama, F., Otagiri, M., Shibata, M., Inclusion complexation of p-hydroxybenzoic acid esters with a and b-cyclodextrins: dissolution behaviour and antimicrobial activities (1980) Yakugaku Zasshi, 100, pp. 994-1003
Chan, L.W., Kurup, T.R.R., Muthaiah, A., Thenmozhiyal, J.C., Interaction of p-hydroxybenzoic esters with b-cyclodextrin (2000) Int. J. Pharm., 195, pp. 71-79
Lehner, S.J., Muller, B.W., Seydel, J.K., Interactions between p-hydroxybenzoic acid-esters and hydroxypropylb-cyclodextrin and their antimicrobial effect against Candida albicans (1993) Int. J. Pharm., 93, pp. 201-208
Lehner, S.J., Muller, B.W., Seydel, J.K., Effect of hydroxypropyl-b-cyclodextrin on the antimicrobial action of preservatives (1994) J. Pharm. Pharmacol., 46, pp. 186-191
Tanaka, M., Iwata, Y., Kouzuki, Y., Taniguchi, K., Matsuda, H., Arima, H., Tsuchiya, S., Effect of 2-hydroxypropyl-b-cyclodextrin on percutaneous absorption of methyl paraben (1995) J. Pharm. Pharmacol., 47, pp. 897-900
Loftsson, T., Stefansdóttir, O., Frioriksdóttir, H., Guomundsson, O., Interactions between preservatives and 2-hydroxypropyl-b-cyclodextrin (1992) Drug Dev. Ind. Pharm., 18, pp. 1477-1484
Shimada, K., Ohe, Y., Ohguni, T., Kawano, K., Ishii, J., Nakamura, T., Emulsifying properties of a-cyclodextrins, b-cyclodextrins and c-cyclodextrins (1991) J. Jpn. Soc. Food Sci. Technol. (Nippon Shokuhin Kagaku Kogaku Kaishi), 38, pp. 16-20
Yu, S.C., Bochot, A., Le Bas, G., Cheron, M., Grossiord, J.L., Seiller, M., Duchêne, D., Characteristics of o/w emulsions containing lipophilic molecules with cyclodextrins as emulsifiers (2001) STP Pharm. Sci., 11, pp. 385-391
Hashizaki, K., Kageyama, T., Inoue, M., Taguchi, H., Ueda, H., Saito, Y., Study on preparation and formation mechanism of n-alkanol/water emulsion using a-cyclodextrin (2007) Chem. Pharm. Bull., 55, pp. 1620-1625
Inoue, M., Hashizaki, K., Taguchi, H., Saito, Y., Emulsion preparation using b-cyclodextrin and its derivatives acting as an emulsifier (2008) Chem. Pharm. Bull., 56, pp. 1335-1337
Yu, S.C., Bochot, A., Cheron, M., Seiller, M., Grossiord, J.L., Le Bas, G., Duchêne, D., Design and evaluation of an original o/w/o multiple emulsion containing natural cyclodextrins as the emulsifier (1999) STP Pharm. Sci., 9, pp. 273-277
Yu, S.C., Bochot, A., Le Bas, G., Cheron, M., Mahuteau, J., Grossiord, J.L., Seiller, M., Duchêne, D., Effect of camphor/cyclodextrin complexation on the stability of o/w/o multiple emulsions (2003) Int. J. Pharm., 261, pp. 1-8
Ducĥene, D., Bochot, A., Yu, S.C., Pepin, C., Seiller, M., Cyclodextrins and emulsions (2003) Int. J. Pharm., 266, pp. 85-90
Duchêne, D., Wouessijewe, D., Poelman, M.C., New Trends in Cyclodextrins and Derivatives (1991), pp. 448-481. , In: Duchêne, D., Ed., Editions de Santé, Paris
Shimada, K., Kawano, K., Ishii, J., Nakamura, T., Structure of inclusion complexes of cyclodextrins with triglyceride at vegetable oil-water interface (1992) J. Food Sci., 57, pp. 655-656
Inoue, M., Hashizaki, K., Taguchi, H., Saito, Y., Formation and characterization of emulsions using b-cyclodextrin as an emulsifier (2008) Chem. Pharm. Bull., 56, pp. 668-671
Inoue, M., Hashizak, I.K., Taguchi, H., Saito, Y., Preparation and characterization of n-alkane/water emulsion stabilized by cyclodextrin (2009) J. Oleo Sci., 58, pp. 85-90
Trichard, L., Fattal, E., Le Bas, G., Duchêne, D., Grossiord, J.L., Bochot, A., Formulation and characterisation of beads prepared from natural cyclodextrins and vegetable, mineral or synthetic oils (2008) Int. J. Pharm., 354, pp. 88-94
Trichard, L., Bochot, A., Duchêne, D., Cyclodextrins in dispersed systems (2006) Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications, pp. 423-446. , In: Dodziuk, D. Ed., Wiley-VCH, Warsaw, Poland
Vyas, A., Saraf, S., Saraf, S., Cyclodextrin based novel drug delivery systems (2008) J. Inclusion Phenom. Macrocyclic Chem., 62, pp. 23-42
Bochot, A., Trichard, L., Le Bas, G., Alphandary, H., Grossiord, J.L., Duchêne, D., Fattal, E., a-cyclodextrin/oil beads: an innovative self-assembling system (2007) Int. J. Pharm., 339, pp. 121-129
Trichard, L., Fattal, E., Besnard, M., Bochot, A., a-Cyclodextrin/oil beads as a new carrier for improving the oral bioavailability of lipophilic drugs (2007) J. Control. Release, 122, pp. 47-53
Trichard, L., Delgado-Charro, M.B., Guy, R.H., Fattal, E., Bochot, A., Novel beads made of a-cyclodextrin and oil for topical delivery of a lipophilic drug (2008) Pharm. Res., 25, pp. 435-440
Daoud-Mahammed, S., Couvreur, P., Amiel, C., Besnard, M., Appel, M., Gref, R., Original tamoxifen-loaded gels containing cyclodextrins: in situ self-assembling systems for cancer treatment (2004) J. Drug Deliv. Sci. Technol., 14, pp. 51-55
Daoud-Mahammed, S., Grossiord, J.L., Bergua, T., Amiel, C., Couvreur, P., Gref, R., Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs (2007) J. Biomed. Mater. Res. A, 86, pp. 736-748
Daoud-Mahammed, S., Couvreur, P., Bouchemal, K., Chéron, M., Le Bas, G., Amiel, C., Gref, R., Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen (2009) Biomacromolecules, 10, pp. 547-554
Bellocq, N.C., Kang, D.W., Wang, X., Jensen, G.S., Pun, S.H., Schluep, T., Zepeda, M.L., Davis, M.E., Synthetic biocompatible cyclodextrin-based constructs for local gene delivery to improve cutaneous wound healing (2004) Bioconjugate Chem., 15, pp. 1201-1211
Lim, H.J., Cho, E.C., Shim, J., Kim, D.H., An, E.J., Kim, J., Polymer-associated liposomes as a novel delivery system for cyclodextrin-bound drugs (2008) J. Colloid Interface Sci., 320, pp. 460-468
Gillet, A., Grammenos, A., Compère, P., Evrard, B., Piel, G., Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome (2009) Int. J. Pharm., 380, pp. 174-180
Loftsson, T., Sigurdardöttir, A.M., Ólafsson, J.H., Improved acitretin delivery through hairless mouse skin by cyclodextrin complexation (1995) Int. J. Pharm., 115, pp. 255-258
Ammar, H.O., Ghorab, M., El-Nahhas, S.A., Kamel, R., Design of a transdermal delivery system for aspirin as an antithrombotic drug (2006) Int. J. Pharm., 327, pp. 81-88
Uekama, K., Otagiri, M., Sakai, A., Irie, T., Matsuo, N., Matsuoka, Y., Improvement in the percutaneous-absorption of beclomethasone dipropionate by c-cyclodextrin complexation (1985) J. Pharm. Pharmacol., 37, pp. 532-535
Otagiri, M., Fujinaga, T., Sakai, A., Uekama, K., Effects of b-cyclodextrins and c-cyclodextrins on release of b-methasone from ointment bases (1984) Chem. Pharm. Bull., 32, pp. 2401-2405
Ammar, H.O., Elnahhas, S.A., Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation: 3 (1995) Bromhexine hydrochloride. Pharmazie, 50, pp. 408-410
Babu, R.J., Dhanasekaran, M., Vaithiyalingam, S.R., Singh, P.N., Pandit, J.K., Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers (2008) Life Sci., 82, pp. 273-278
Babu, R.J., Pandit, J.K., Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems (2005) Int. J. Pharm., 288, pp. 325-334
Lee, B.J., Choi, H.G., Kim, C.K., Parrott, K.A., Ayres, J.W., Sack, R.L., Solubility and stability of melatonin in propylene glycol and 2-hydroxypropyl-b-cyclodextrin vehicles (1997) Arch. Pharm. Res., 20, pp. 560-565
Zi, P., Yang, X.H., Kuang, H.F., Yang, Y.S., Yu, L.L., Effect of HP-b-CD on solubility and transdermal delivery of capsaicin through rat skin (2008) Int. J. Pharm., 358, pp. 151-158
Shaker, D.S., Ghanem, A.H., Li, S.K., Warner, K.S., Hashem, F.M., Higuchi, W.I., Mechanistic studies of the effect of hydroxypropyl-b-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin (2003) Int. J. Pharm., 253, pp. 1-11
Ceschel, G.C., Mora, P.C., Borgia, S.L., Maffei, P., Ronchi, C., Skin permeation study of dehydroepiandrosterone (DHEA) compared with its a-cyclodextrin complex form (2002) J. Pharm. Sci., 91, pp. 2399-2407
Ceschel, G., Bergamante, V., Maffei, P., Borgia, S.L., Calabrese, V., Biserni, S., Ronchi, C., Solubility and transdermal permeation properties of a dehydroepiandrosterone cyclodextrin complex from hydrophilic and lipophilic vehicles (2005) Drug Deliv., 12, pp. 275-280
Dias, M.M.R., Raghavan, S.L., Pellett, M.A., Hadgraft, J., The effect of b-cyclodextrins on the permeation of diclofenac from supersaturated solutions (2003) Int. J. Pharm., 263, pp. 173-181
Loftsson, T., Bodor, N., Effects of 2-hydroxypropylb-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17-b-estradiol (1989) Acta Pharm. Nord., 1, pp. 185-194
Loftsson, T., Fridriksdóttir, H., Olafsdóttir, B.J., Gudmundsson, O., Solubilization and stabilization of drugs through cyclodextrin complexation (1991) Acta Pharm. Nord., 3, pp. 215-217
Williams, A., Shatri, S., Barry, B., Transdermal permeation modulation by cyclodextrins: a mechanistic study (1998) Pharm. Dev. Technol., 3, pp. 283-296
Arima, H., Miyaji, T., Irie, T., Hirayama, F., Uekama, K., Enhancing effect of hydroxypropyl-b-cyclodextrin on cutaneous penetration activation of ethyl 4-biphenylyl acetate in hairless mouse skin (1998) Eur. J. Pharm. Sci., 6, pp. 53-59
Maitre, M.M., Longhi, M.R., Granero, G.G., Ternary complexes of flurbiprofen with HP-b-CD and ethanolamines characterization and transdermal delivery (2007) Drug Dev. Ind. Pharm., 33, pp. 311-326
Ammar, H.O., Salama, H.A., Ghorab, M., El-Nahhas, S.A., Elmotasem, H., A transdermal delivery system for glipizide (2006) Curr. Drug Deliv., 3, pp. 333-341
Sridevi, S., Diwan, P.V., Effect of pH and complexation on transdermal permeation of gliquidone (2002) Pharmazie, 57, pp. 632-634
Loftsson, T., Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of watersoluble polymers (1998) Pharmazie, 53, pp. 733-740
Loftsson, T., Sigurardóttir, A., The effect of polyvinylpyrrolidone and hydroxypropyl methylcellulose on HPb-CD complexation of hydrocortisone and its permeability through hairless mouse skin (1994) Eur. J. Pharm. Sci., 2, pp. 297-301
Siguroardóttir, A.M., Loftsson, T., The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin (1995) Int. J. Pharm., 126, pp. 73-78
Preiss, A., Mehnert, W., Fromming, K.H., Penetration of hydrocortisone into excised human skin under the influence of cyclodextrins (1995) Pharmazie, 50, pp. 121-126
Kear, C.L., Yang, J., Godwin, D.A., Felton, L.A., Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery (2008) Drug Dev. Ind. Pharm., 34, pp. 692-697
Chang, S., Banga, A., Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions (1998) J. Pharm. Pharmacol., 50, pp. 635-640
Iervolino, M., Cappello, B., Raghavan, S.L., Hadgraft, J., Penetration enhancement of ibuprofen from supersaturated solutions through human skin (2001) Int. J. Pharm., 212, pp. 131-141
Godwin, D.A., Wiley, C.J., Felton, L.A., Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen (2006) Eur. J. Pharm. Biopharm., 62, pp. 85-93
Nagarsenker, M., Amin, L., Date, A., Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation (2008) AAPS PharmSciTech, 9, pp. 1165-1170
Sridevi, S., Diwan, P.V.R., Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-b-cyclodextrin as co-enhancers (2002) Eur. J. Pharm. Biopharm., 54, pp. 151-154
Valjakka-Koskela, R., Hirvonen, J., Monkkonen, J., Kiesvaara, J., Antila, S., Lehtonen, L., Urtti, A., Transdermal delivery of levosimendan (2000) Eur. J. Pharm. Sci., 11, pp. 343-350
Padula, C., Pappani, A., Santi, P., In vitro permeation of levothyroxine across the skin (2008) Int. J. Pharm., 349, pp. 161-165
Vollmer, U., Muller, B.W., Mesens, J., Wilffert, B., Peters, T., In-vivo skin pharmacokinetics of liarozole: percutaneous-absorption studies with different formulations of cyclodextrin derivatives in rats (1993) Int. J. Pharm., 99, pp. 51-58
Bodor, N., Loftsson, T., Wu, W.M., Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate (1992) Pharm. Res., 9, pp. 1275-1278
Martins, P.S., Ochoa, R., Pimenta, A.M.C., Ferreira, L.A.M., Melo, A.L., Da Silva, J.B.B., Sinisterra, R.D., Frezard, F., Mode of action of b-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate (2006) Int. J. Pharm., 325, pp. 39-47
Lee, B.J., Cui, J.H., Parrott, K.A., Ayres, J.W., Sack, R.L., Percutaneous absorption and model membrane variations of melatonin in aqueous-based propylene glycol and 2-hydroxypropyl-b-cyclodextrin vehicles (1998) Arch. Pharm. Res., 21, pp. 503-507
Bounoure, F., Skiba, M.L., Besnard, M., Arnaud, P., Mallet, E., Skiba, M., Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine (2008) J. Dermatol. Sci., 52, pp. 170-177
Tenjarla, S., Puranajoti, P., Kasina, R., Mandal, T., Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery (1998) J. Pharm. Sci., 87, pp. 425-429
Kim, J., Kim, M., After-rinsing hair growth promotion of minoxidil-containing amino a-cyclodextrins (2007) J. Microbiol. Biotechnol., 17, pp. 1965-1969
Kim, J.C., Lee, M.H., Rang, M.J., Minoxidil-containing dosage forms: skin retention and after-rinsing hair-growth promotion (2003) Drug Deliv., 10, pp. 119-123
Davaran, S., Rashidi, M.R., Khandaghi, R., Hashemi, M., Development of a novel prolonged-release nicotine transdermal patch (2005) Pharmacol. Res., 51, pp. 233-237
Dalmora, M.E., Dalmora, S.L., Oliveira, A.G., Inclusion complex of piroxicam with b-cyclodextrin and incorporation in cationic microemulsion: in vitro drug release and in vivo topical anti-inflammatory effect (2001) Int. J. Pharm., 222, pp. 45-55
Adachi, H., Irie, T., Kaneto, U., Combination effects of O-carboxymethyl-O-ethyl-b-cyclodextrin and penetration enhancer HPE-101 on transdermal delivery of prostaglandin E1 in hairless mice (1993) Eur. J. Pharm. Sci., 1, pp. 117-123
Larrucea, E., Arellano, A., Santoyo, S., Ygartua, P., Study of the complexation behavior of tenoxicam with cyclodextrins in solution: improved solubility and percutaneous permeability (2002) Drug Dev. Ind. Pharm., 28, pp. 245-252
Larrucea, E., Arellano, A., Santoyo, S., Ygartua, P., Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin (2001) Eur. J. Pharm. Biopharm., 52, pp. 113-119
Szemán, J., Ueda, H., Szejtli, J., Fenyvesi, E., Watanabe, Y., Machida, Y., Nagai, T., Enhanced percutaneous absorption of homogenized tolnaftate/b-cyclodextrin polymer ground mixture (1987) Drug Des. Deliv., 1, pp. 325-332
Tanner, T., Marks, R., Delivering drugs by the transdermal route: review and comment (2008) Skin Res. Technol., 14, pp. 249-260
Doliwa, A., Santoyo, S., Ygartua, P., Transdermal iontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-b-cyclodextrin complexes (2001) Drug Dev. Ind. Pharm., 27, pp. 751-758
Doliwa, A., Santoyo, S., Ygartua, P., Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam (2001) Int. J. Pharm., 229, pp. 37-44
Murthy, S.N., Zhao, Y.L., Sen, A., Hui, S.W., Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation (2004) J. Control. Release, 99, pp. 393-402
Jin, S., Lee, Y., Kang, H., Methyl-b-cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERK (2008) Arch. Dermatol. Res., 300, pp. 451-454
Kim, S., Kim, Y., Lee, Y., Cho, K.H., Kim, K.H., Chung, J.H., Cholesterol inhibits MMP-9 expression in human epidermal keratinocytes and HaCaT cells (2007) FEBS Lett., 581, pp. 3869-3874
Gniadecki, R., Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis (2004) Biochem. Biophys. Res. Commun., 320, pp. 165-169
Leppimaki, P., Kronqvist, R., Slotte, J., The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts (1998) Biochem. J., 335, pp. 285-291
Sviridov, D., Fidge, N., Beaumier-Gallon, G., Fielding, C., Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae) (2001) Biochem. J., 358, pp. 79-86
Gniadecki, R., Christoffersen, N., Wulf, H.C., Cholesterol-rich plasma membrane domains (lipid rafts) in keratinocytes: importance in the baseline and UVA-induced generation of reactive oxygen species (2002) J. Invest. Dermatol., 118, pp. 582-588
Jans, R., Atanasova, G., Jadot, M., Poumay, Y., Cholesterol depletion alters involucrin gene expression in epidermal keratinocytes through activation of p38 (2004) J. Invest. Dermatol., 122, pp. 94-94
Bang, B., Gniadecki, R., Gajkowska, B., Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes (2005) Exp. Dermatol., 14, pp. 266-272
Zimina, E., Bruckner-Tuderman, L., Franzke, C., Shedding of collagen XVII ectodomain depends on plasma membrane microenvironment (2005) J. Biol. Chem., 280, pp. 34019-34024
Lambert, S., Vind-Kezunovic, D., Karvinen, S., Gniadecki, R., Ligand-independent activation of the EGFR by lipid raft disruption (2006) J. Invest. Dermatol., 126, pp. 954-962
Lisby, S., Faurschou, A., Gniadecki, R., The autocrine TNFa signalling loop in keratinocytes requires atypical PKC species and NF-kB activation but is independent of cholesterol-enriched membrane microdomains (2007) Biochem. Pharmacol., 73, pp. 526-533
Duchêne, D., Bochot, A., Loftsson, T., Les cyclodextrines et leurs utilisations en pharmacie et cosmétologie (2009) STP Pharma Pratiques, 19, pp. 15-27
